A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program

Peckham, Alyssa M.; Niculete, Maria E.; Steinberg, Howard R.; Boggs, Douglas L.

doi:10.1097/phh.0000000000000668

Cited by 31 publications

(32 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five studies examined training and education programs for practicing pharmacists. 45,[47][48][49][50] State-mandated training requirements were reviewed for pharmacists dispensing naloxone in states where the legislatures permitted enhanced access to naloxone through pharmacies. 47 To date, all states except Nebraska have enhanced pharmacy naloxone access laws, including 43 states with standing orders and 14 state with protocol orders.…”

Section: Programs For Practicing Pharmacistsmentioning

confidence: 99%

“…Prescribers who had received training were more comfortable with and expressed less lack of knowledge about opioid overdose and naloxone dispensing compared with those without training, and prescribers who specialized in substance use disorders were most comfortable with and knowledgeable about these topics. 48 Overall, much variability exists among naloxone training and education programs, with major differences in program content, requirements for mandatory or voluntary completion, and frequency of completion.…”

Section: Programs For Practicing Pharmacistsmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review

Thakur¹,

Frey²,

Chewning³

2020

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Section: Programs For Practicing Pharmacistsmentioning

confidence: 99%

Section: Programs For Practicing Pharmacistsmentioning

confidence: 99%

Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review

Thakur¹,

Frey²,

Chewning³

2020

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

“…Successful implementation of THN would result in widespread acceptability and availability of the intervention, such that it is accessed by relevant target populations and embedded in usual practice in drug treatment and mainstream health services. A number of papers have explored legal [142] and workforce [143, 144] barriers. These have been country and region specific.…”

Section: Barriers To Wider Implementationmentioning

confidence: 99%

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

Strang

McDonald

Campbell

et al. 2019

Drugs

View full text Add to dashboard Cite

Naloxone is a well-established essential medicine for the treatment of life-threatening heroin/opioid overdose in emergency medicine. Over two decades, the concept of ‘take-home naloxone’ has evolved, comprising pre-provision of an emergency supply to laypersons likely to witness an opioid overdose (e.g. peers and family members of people who use opioids as well as non-medical personnel), with the recommendation to administer the naloxone to the overdose victim as interim care while awaiting an ambulance. There is an urgent need for more widespread naloxone access considering the growing problem of opioid overdose deaths, accounting for more than 100,000 deaths worldwide annually. Rises in mortality are particularly sharp in North America, where the ongoing prescription opioid problem is now overlaid with a rapid growth in overdose deaths from heroin and illicit fentanyl. Using opioids alone is dangerous, and the mortality risk is clustered at certain times and contexts, including on prison release and discharge from hospital and residential care. The provision of take-home naloxone has required the introduction of new legislation and new naloxone products. These include pre-filled syringes and auto-injectors and, crucially, new concentrated nasal sprays (four formulations recently approved in different countries) with speed of onset comparable to intramuscular naloxone and relative bioavailability of approximately 40–50%. Choosing the right naloxone dose in the fentanyl era is a matter of ongoing debate, but the safety margin of the approved nasal sprays is superior to improvised nasal kits. New legislation in different countries permits over-the-counter sales or other prescription-free methods of provision. However, access remains uneven with take-home naloxone still not provided in many countries and communities, and with ongoing barriers contributing to implementation inertia. Take-home naloxone is an important component of the response to the global overdose problem, but greater commitment to implementation will be essential, alongside improved affordable products, if a greater impact is to be achieved.

show abstract

“…Thus, without expanding beyond the minimum required opioid objectives, recent primary care training program graduates experience inadequate preparation to meet the needs of the opioid epidemic. While some training programs that have integrated components of opioid use disorders and overdose treatment report increase in knowledge, efficacy, and attitudes for health care professional trainees, the current climate of practicing physicians’ low comfort and confidence in educating patients in and prescribing life-saving naloxone suggests that further programming is necessary 16,20,24-27…”

Section: Introductionmentioning

confidence: 99%

Evaluation of an interprofessional naloxone didactic and skills session with medical residents and physician assistant learners

Hargraves¹,

White²,

Mauger³

et al. 2019

Pharm Pract (Granada)

View full text Add to dashboard Cite

Background:The CDC has reported 399,230 opioid-related deaths from 1999-2017. In 2018, the US surgeon general issued a public health advisory, advising all Americans to carry naloxone. Studies show that enhanced naloxone access directly reduces death from opioid overdose. Despite this, health care professional learners report low knowledge and confidence surrounding naloxone. Therefore, it becomes critical that medical education programs incorporate didactic and experiential sessions improving knowledge, skills and attitudes regarding harm reduction through naloxone.Objectives:1. Describe the components and evaluation of a replicable and adaptable naloxone didactic and skills session model for medical providers; 2. Report the results of the evaluation from a pilot session with family medicine residents and physician assistant students; and 3. Share the session toolkit, including evaluation surveys and list of materials used.Methods:In July 2017, a literature search was completed for naloxone skill training examining best practices on instruction and evaluation. A training session for family medicine residents and physician assistant learners was designed and led by University of Cincinnati College of Medicine and College of Pharmacy faculty. The same faculty designed a pre and post session evaluation form through internal review on elements targeting naloxone knowledge, attitude, and self-efficacy.Results:The training session included one hour for a didactic and one hour for small group live skills demonstration in four methods of naloxone administration (syringe and ampule, nasal atomizer, branded nasal spray and auto injector). Forty-eight participants showed statistically significant (p<0.05) improvement in knowledge (67.5% to 95.9%), attitudes (71.2% to 91.2%), and self-efficacy (62.1% to 97.8%) from pre to post assessment. Forty-four of 48 participants agreed that the pace of the training was appropriate and that the information will be of use in their respective primary care practices. Supply costs for the session were USD 1,200, with the majority being reusable on subsequent trainings.Conclusions:Our study of a naloxone didactic and skills session for primary care trainees demonstrated significant improvements in knowledge, self-efficacy, and attitudes. It provides an adaptable and efficient model for delivery of knowledge and skills in naloxone administration training. The pilot data suggest that the training was efficacious.

show abstract

A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program

Cited by 31 publications

References 17 publications

Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review

Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

Evaluation of an interprofessional naloxone didactic and skills session with medical residents and physician assistant learners

Contact Info

Product

Resources

About